EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Nanovaccines in cancer immunoprevention and immunotherapy: Current insights and future directions

Daniel Ejim Uti, Esther Ugo Alum, Okechukwu Paul-Chima Ugwu

Cancer Treatment and Research Communications · 2026 · 47 · 101166

DOI: 10.1016/j.ctarc.2026.101166 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Daniel Ejim Uti und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Basic Medical Sciences, College of Medicine, Federal University of Health Sciences, Otukpo, Benue State, Niger…. Hauptthemen laut MEDLINE: Nanovaccines, Immunotherapy, Neoplasms, Cancer Vaccines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 205 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

• Nanovaccines enhance immune activation, antigen loading, and precise tumor targeting efficiency. • The review classifies nanovaccines as therapeutic (anti-tumor) or prophylactic (anti-cancer) tools. • Its discusses nanocarriers like liposomes, polymers, gold nanoparticles, and virus-like particles. • Its explores bioinspired, stimuli-responsive delivery for optimal immune stimulation and uptake. • Its covers clinical progress, translational hurdles, mRNA platforms, and AI-driven vaccine design. Cancer is one of the most problematic health challenge on a global scale and new ways need to be found for its prevention and treatment. Cancer immunotherapy has become a powerful strategy for activating the immune system into fighting the tumor, whereas cancer immunoprevention is attempting to generate protective immunity prior to the development of malignancy. Nanovaccines represent one of the pulling forces of the emerging strategies that possess the power to revolutionize cancer immunoprevention and immunotherapy. And when nanovaccines are combined with immunological principles, antigen loading can be accomplished more efficiently, the immune system is activated to a better extent and correct targeting activity is improved compared with the conventional vaccine vehicles. Complete analysis of nanovaccines in cancer management is provided, classifying them into anti-tumor and anti-cancer categories. It details nanocarrier systems like liposomes and gold nanoparticles, exploring their mechanisms and immunological effects. The review discusses innovative delivery methods, clinical advancements, and challenges including regulatory barriers and safety. Emphasis is placed on trends like neoantigen-based nanovaccines, mRNA platforms, and the role of artificial intelligence. The convergence of cancer immunotherapy and nanotechnology promises significant advancements in cancer prevention and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanovaccinesImmunotherapyNeoplasmsCancer VaccinesHumansAnimalsAntigens, Neoplasm

Stichwörter der Autor:innen

Cancer immunotherapyImmune modulationImmunopreventionNanovaccinesTumor antigens

Substanzen

NanovaccinesCancer VaccinesAntigens, Neoplasm

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Basic Medical Sciences, College of Medicine, Federal University of Health Sciences, Otukpo, Benue State, Nigeria; Department of Biochemistry, Research and Publications, Kampala Int…
  • Department of Biochemistry, Research and Publications, Kampala International University, P.O. Box 20000, Kampala, Uganda; Department of Biochemistry, Faculty of Science, Ebonyi State University, Abakaliki, Nigeria.
  • Department of Biochemistry, Research and Publications, Kampala International University, P.O. Box 20000, Kampala, Uganda.

Zitieren

APA

Uti, D. E., Alum, E. U., & Ugwu, O. P. (2026). Nanovaccines in cancer immunoprevention and immunotherapy: Current insights and future directions. Cancer Treatment and Research Communications, 47, 101166. https://doi.org/10.1016/j.ctarc.2026.101166

Vancouver

Uti DE, Alum EU, Ugwu OP. Nanovaccines in cancer immunoprevention and immunotherapy: Current insights and future directions. Cancer Treatment and Research Communications. 2026;47:101166. doi:10.1016/j.ctarc.2026.101166

BibTeX
@article{Uti2026,
  author = {Uti, Daniel Ejim and Alum, Esther Ugo and Ugwu, Okechukwu Paul-Chima},
  title = {Nanovaccines in cancer immunoprevention and immunotherapy: Current insights and future directions},
  journal = {Cancer Treatment and Research Communications},
  year = {2026},
  volume = {47},
  pages = {101166},
  doi = {10.1016/j.ctarc.2026.101166}
}
Kostenlos starten →